Hirofumi Takeuchi

Prof. Dr. Hirofumi Takeuchi

Laboratory of Advanced Pharmaceutical Process Engineering, Gifu Pharmaceutical University, Gifu 501-1196, Japan

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2005 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi
JTJ Thongborisute
J Thongborisute
YMY Matsui
Y Matsui
HSH Sugihara
H Sugihara
HYH Yamamoto
H Yamamoto
YKY Kawashima
Y Kawashima

1 January 2003 in Journal of Controlled Release
Verified
Journal Article
Closed access
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi
YMY Matsui
Y Matsui
HYH Yamamoto
H Yamamoto
YKY Kawashima
Y Kawashima

1 October 2005 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi
YMYuji Matsui
Yuji Matsui
HSHikaru Sugihara
Hikaru Sugihara
HYHiromitsu Yamamoto
Hiromitsu Yamamoto
YKYoshiaki Kawashima
Yoshiaki Kawashima

1 July 2017 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
KTKohei Tahara
Kohei Tahara
KKKeiichi Karasawa
Keiichi Karasawa
RORisako Onodera
Risako Onodera
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi
We investigated the delivery of drugs to the posterior segment of the eye by non-invasive topical instillation using submicron-sized poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). Surface-modified PLGA NPs were developed to improve the drug delivery efficiency to the retina and were administered as topical eye drops to mice. Chitosan (CS) and glycol chitosan (GCS), which are mucoadhesive polymers, and polysorbate 80 (P80) were used as surface modifiers, and have been reported to increase the association of NPs with cells. Coumarin-6 was used as a model drug and fluorescent marker, and after ocular administration of PLGA NP eye drops, the fluorescence intensity of coumarin-6 was observed in the retina. The fluorescence image analysis indicated that there are several possible routes to the retina and fates of PLGA NPs in ocular tissue, and that these pathways involved the corneal, non-corneal, or uveal routes. Delivery to the mouse retina segments after topical administration was increased by surface modification with CS, GCS, or P80. Surface-modified PLGA NPs are a promising method for retinal drug delivery via topical instillation.

1 August 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
TOTakashi Osamura
Takashi Osamura
YTYoshiko Takeuchi
Yoshiko Takeuchi
RORisako Onodera
Risako Onodera
MKMasahiro Kitamura
Masahiro Kitamura
YTYoshiteru Takahashi
Yoshiteru Takahashi
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi

1 January 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MMMitsutaka Murata
Mitsutaka Murata
KTKohei Tahara
Kohei Tahara
Hirofumi TakeuchiHirofumi Takeuchi
Hirofumi Takeuchi